Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mifepristone crossover trial for depression in Parkinson's disease
ACTRN12606000253505Phase 3Recruiting
- Sponsor
- Neurological Foundation
- Start
- Mar 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of mifepristone in major depressive disorder (MDD) and Parkinson's disease (PD), sponsored by Neurological Foundation. Started Mar 2006; status: recruiting.
02
Drugs
mifepristone
03
Conditions
major depressive disorder (MDD)Parkinson's disease (PD)
Beyond the preview
Go deeper on ACTRN12606000253505.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12606000253505.